These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5012012)

  • 21. [Drug information: agents for the treatment of cardiac arrhythmias. 5. (2) Arrhythmias relieved by changed impulse conduction/changed cellular reaction pattern].
    Lumholtz IB
    Sygeplejersken; 1980 Jul; 80(30):15. PubMed ID: 6905368
    [No Abstract]   [Full Text] [Related]  

  • 22. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studying the mechanism of antiarrhythmic action of a tertiary derivative of lidocaine].
    Blinov DS; Kostin IaV; Skachilova SIa
    Eksp Klin Farmakol; 2004; 67(3):18-20. PubMed ID: 15341061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of antiarrhythmics on intracardial excitation conduction in His-bundle electrography].
    Seipel L; Gleichmann U; Loogen F
    Verh Dtsch Ges Inn Med; 1973; 79():993-6. PubMed ID: 4790065
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiological studies and cardioactive drugs.
    Vohra J; Ross D; Sloman G
    Indian Heart J Teach Ser; 1980; (7):285-9. PubMed ID: 7309048
    [No Abstract]   [Full Text] [Related]  

  • 26. [The mechanism of antiarrhythmic action of a new ammonium derivative of lidocaine (LKhT-12-02)].
    Blinov DS; Balashov VP; Sernov LN; Kazachenko VN; Blinova EV; Belova LA; Astashev ME
    Eksp Klin Farmakol; 2006; 69(6):31-3. PubMed ID: 17209461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical development of an anti-arrhythmic. Human electrophysiology].
    Libersa C; Caron J; Lekieffre J
    Therapie; 1986; 41(2):87-93. PubMed ID: 3726795
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions].
    Weiss-Simon C; Spangenberg G; Michel D
    Fortschr Med; 1980 Apr; 98(15):569-72. PubMed ID: 7390368
    [No Abstract]   [Full Text] [Related]  

  • 29. [Electrophysiologic effects of lorcainide (R 15889) in man].
    Touboul P; Atallah G; Kirkorian G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1333-40. PubMed ID: 6797372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical pharmacology of anti-arrhythmia agents].
    Azanza Perea JR; Honorato Pérez JM; Cuena Boy R
    Rev Med Univ Navarra; 1984 Mar; 28(1):37-43. PubMed ID: 6147005
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone.
    Keller K; Meyer-Estorf G; Beck OA; Hochrein H
    Eur J Clin Pharmacol; 1978 Mar; 13(1):17-20. PubMed ID: 639829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological restoration and maintenance of sinus rhythm by antiarrhythmic agents].
    Sugi K
    J Cardiol; 1999 Mar; 33 Suppl 1():59-64. PubMed ID: 10342138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of several anti-arrhythmia agents on excitability and conduction depressed by digitalis agents].
    Márquez M; Kabela E
    Arch Inst Cardiol Mex; 1984; 54(6):535-44. PubMed ID: 6241458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial-specific drugs: the way to treat atrial fibrillation?
    Vos MA
    J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1451-2. PubMed ID: 15610295
    [No Abstract]   [Full Text] [Related]  

  • 35. Arrhythmias and antiarrhythmic drugs.
    Urthaler F
    Ala J Med Sci; 1984 Jul; 21(3):275-83. PubMed ID: 6476289
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electrophysiologic characterization of propafenone in man].
    Masini G; Dianda R; Masini M
    G Ital Cardiol; 1984 Apr; 14(4):293-6. PubMed ID: 6735022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endocavitary study of Lorcainide (author's transl)].
    Depaepe A; Sartieaux A; De Mey D
    Rev Med Brux; 1980 Mar; 1(3):157-9. PubMed ID: 7466015
    [No Abstract]   [Full Text] [Related]  

  • 38. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
    Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.